Kei Kaneko

Kasugai, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

GD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics.

GD2 is a Crucial Ganglioside in the Signal Modulation and Application as a Target of Cancer Therapeutics.

Journal: Cancer science

Published: November 21, 2024

Action Mechanisms of Exosomes Derived from GD3/GD2-Positive Glioma Cells in the Regulation of Phenotypes and Intracellular Signaling: Roles of Integrins.

Action Mechanisms of Exosomes Derived from GD3/GD2-Positive Glioma Cells in the Regulation of Phenotypes and Intracellular Signaling: Roles of Integrins.

Journal: International journal of molecular sciences

Published: October 21, 2024

No gender difference in cardiac interoceptive accuracy: Potential psychophysiological contributors in heartbeat counting task.

No gender difference in cardiac interoceptive accuracy: Potential psychophysiological contributors in heartbeat counting task.

Journal: BMC psychology

Published: July 03, 2024

Crucial roles of exosomes secreted from ganglioside GD3/GD2-positive glioma cells in enhancement of the malignant phenotypes and signals of GD3/GD2-negative glioma cells.

Crucial roles of exosomes secreted from ganglioside GD3/GD2-positive glioma cells in enhancement of the malignant phenotypes and signals of GD3/GD2-negative glioma cells.

Journal: Nagoya journal of medical science

Published: December 04, 2023

Possible regulation of ganglioside GD3 synthase gene expression with DNA methylation in human glioma cells.

Possible regulation of ganglioside GD3 synthase gene expression with DNA methylation in human glioma cells.

Journal: Glycoconjugate journal

Published: November 30, 2022

Extracellular vesicles released from ganglioside GD2-expressing melanoma cells enhance the malignant properties of GD2-negative melanomas.

Extracellular vesicles released from ganglioside GD2-expressing melanoma cells enhance the malignant properties of GD2-negative melanomas.

Journal: Scientific reports

Published: September 30, 2022

Signaling domains of cancer-associated glycolipids.

Signaling domains of cancer-associated glycolipids.

Journal: Glycoconjugate journal

Published: December 18, 2021

Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.

Ganglioside GD2 Enhances the Malignant Phenotypes of Melanoma Cells by Cooperating with Integrins.

Journal: International journal of molecular sciences

Published: October 30, 2021

St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity.

St8sia1-deficiency in mice alters tumor environments of gliomas, leading to reduced disease severity.

Journal: Nagoya journal of medical science

Published: November 18, 2020

Neogenin, Defined as a GD3-associated Molecule by Enzyme-mediated Activation of Radical Sources, Confers Malignant Properties via Intracytoplasmic Domain in Melanoma Cells.

Neogenin, Defined as a GD3-associated Molecule by Enzyme-mediated Activation of Radical Sources, Confers Malignant Properties via Intracytoplasmic Domain in Melanoma Cells.

Journal: The Journal of biological chemistry

Published: December 07, 2015

Proteomic analysis of ganglioside-associated membrane molecules: substantial basis for molecular clustering.

Proteomic analysis of ganglioside-associated membrane molecules: substantial basis for molecular clustering.

Journal: Proteomics

Published: July 04, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026